A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
11/10/2021 - 10 minutes
Pfizer
Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
Despite the widespread rollout of vaccines this year, the Covid-19 pandemic remains a threat to…
27/08/2021 - 7 minutes
EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19
BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its…
22/12/2020 - 5 minutes
Covid-19 Pandemic Drives RNA Therapeutics into the Mainstream
With messenger RNA being pushed to the market in record time and Alnylam’s historic approval…
02/12/2020 - 8 minutes
mRNA Stocks Soar with Final Results of BioNTech’s Covid-19 Vaccine
The field of messenger RNA therapeutics is flying high as BioNTech and Pfizer conclude a…
19/11/2020 - 6 minutes
Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise
A vaccine made out of messenger RNA (mRNA), developed by the US pharmaceutical giant Pfizer…
03/07/2020 - 3 minutes
Lyme Disease Vaccine Gets Pfizer’s Backing in €284M Deal
The French biotech Valneva will collaborate with Pfizer to develop and commercialize Valneva’s phase II-stage…
07/05/2020 - 4 minutes
Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans
Update (29/04/2020): A vaccine developed by the German company BioNTech and its big pharma partner…
29/04/2020 - 5 minutes
Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment
The founders of Swiss biotech Therachon have launched a new company called VectivBio, also based…
08/01/2020 - 2 minutes
Finnish Genetics Study Provides Clues for Treating Type 2 Diabetes
A genetic mutation common to Finnish populations has been found to protect against type 2…
04/11/2019 - 2 minutes
European Project Launches to Tailor Autoimmune Disease Treatments
Public and private organizations across Europe will pool their resources in an €80M project to…
31/10/2019 - 2 minutes
Pfizer Pays up to €700M to Acquire Swiss Biotech Restoring Bone Growth in Achondroplasia
Pharma giant Pfizer is acquiring the Swiss biotech Therachon, which is developing a protein drug…
09/05/2019 - 2 minutes
